Search

Author/Creator Santos, Breno R.

1. Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings. (15th July 2021)

Authors:
Apornpong, Tanakorn; Grinsztejn, Beatriz; Hughes, Michael; Ritz, Justin; Kerr, Stephen J.; Fletcher, Courtney V.; Ruxrungtham, Kiat; Godfrey, Catherine; Gross, Robert; Hogg, Evelyn; Wallis, Carole L.; Badal-Faesen, Sharlaa; Hosseinipour, Mina C.; Mngqbisa, Rosie; Santos, Breno R.; Shah, Sarita; H...
Journal:
AIDS
Issue:
Volume 35:Number 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment. (1st July 2016)

Authors:
Fogel, Jessica M.; Hudelson, Sarah E.; Ou, San-San; Hart, Stephen; Wallis, Carole; Morgado, Mariza G.; Saravanan, Shanmugam; Tripathy, Srikanth; Hovind, Laura; Piwowar-Manning, Estelle; Sabin, Devin; McCauley, Marybeth; Gamble, Theresa; Zhang, Xinyi C.; Eron, Joseph J.; Gallant, Joel E.; Kumwenda...
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 72:Number 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052. (15th April 2018)

Authors:
Palumbo, Philip J.; Fogel, Jessica M.; Hudelson, Sarah E.; Wilson, Ethan A.; Hart, Stephen; Hovind, Laura; Piwowar-Manning, Estelle; Wallis, Carole; Papathanasopoulos, Maria A.; Morgado, Mariza G.; Saravanan, Shanmugam; Tripathy, Srikanth; Eron, Joseph J.; Gallant, Joel E.; McCauley, Marybeth; Ga...
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 77:Number 5(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial. Issue 6 (15th June 2022)

Authors:
Avihingsanon, Anchalee; Hughes, Michael D.; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn; Mugyenyi, Peter; Hogg, Evelyn; Gross, Robert; Cardoso, Sandra W.; Bukuru, Aggrey; Makanga, Mumbi; Badal‐aesen, Sharlaa; Mave, Vidya; Ndege, Beatrice Wangari; Fontain, Sandy Nerette; Samaneka, Wadzan...
Journal:
Journal of the International AIDS Society
Issue:
Volume 25:Issue 6(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗